Pharma GCCs vs. Agencies: A Strategic Disruption

Pharmaceutical companies are rapidly building sophisticated Global Capability Centers (GCCs) that directly compete with traditional agencies. With 65% of top pharma companies now running creative operations in-house and managing 70% of digital asset production internally, the healthcare advertising landscape is undergoing fundamental transformation.

 

This analysis by our team reveals how pharma GCCs have evolved into full-stack marketing powerhouses while exposing critical gaps in agency GCC strategies. The report provides strategic imperatives for agency transformation, competitive analysis across 25+ capabilities, and practical roadmaps for both pharma and agency organizations navigating this $3.7 billion market disruption.

 

Download the full report for actionable frameworks and benchmarking data that industry leaders are using to turn disruption into competitive advantage.